Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swiss (SMI) Pharma Industry Analysis

UpdatedAug 08, 2025
DataAggregated Company Financials
Companies9
  • 7D-1.5%
  • 3M2.5%
  • 1Y-1.8%
  • YTD3.3%

Over the last 7 days, the Pharma industry has dropped 1.5%, driven by Roche Holding declining 3.1%. On the other hand Sandoz Group is actually up 8.1%. As for the longer term, the industry's performance has been flat for the past year. As for the next few years, earnings are expected to grow by 13% per annum.

Industry Valuation and Performance

Has the Swiss Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 08 Aug 2025CHF 451.8bCHF 120.7bCHF 20.9b22.5x21.6x3.7x
Sun, 06 Jul 2025CHF 452.9bCHF 117.1bCHF 18.9b25x24x3.9x
Tue, 03 Jun 2025CHF 447.6bCHF 118.6bCHF 19.2b25.4x23.3x3.8x
Thu, 01 May 2025CHF 441.8bCHF 119.1bCHF 19.3b25.9x22.9x3.7x
Sat, 29 Mar 2025CHF 467.4bCHF 121.7bCHF 19.2b28.5x24.3x3.8x
Mon, 24 Feb 2025CHF 482.9bCHF 122.3bCHF 19.1b23.4x25.3x3.9x
Wed, 22 Jan 2025CHF 444.3bCHF 119.5bCHF 21.4b18.5x20.8x3.7x
Fri, 20 Dec 2024CHF 415.2bCHF 119.0bCHF 21.3b17.5x19.5x3.5x
Sun, 17 Nov 2024CHF 430.9bCHF 118.3bCHF 21.2b18.4x20.3x3.6x
Tue, 15 Oct 2024CHF 457.6bCHF 115.3bCHF 19.4b21.7x23.6x4x
Thu, 12 Sep 2024CHF 452.7bCHF 115.0bCHF 19.3b21.6x23.4x3.9x
Sat, 10 Aug 2024CHF 456.9bCHF 115.8bCHF 19.5b21.6x23.5x3.9x
Mon, 08 Jul 2024CHF 430.8bCHF 116.2bCHF 19.7b34.1x21.8x3.7x
Wed, 05 Jun 2024CHF 414.3bCHF 115.9bCHF 19.7b44.4x21x3.6x
Fri, 03 May 2024CHF 388.3bCHF 113.4bCHF 19.9b38.9x19.5x3.4x
Sun, 31 Mar 2024CHF 407.1bCHF 112.0bCHF 19.4b38.1x21x3.6x
Tue, 27 Feb 2024CHF 387.6bCHF 110.4bCHF 19.7b24.8x19.7x3.5x
Thu, 25 Jan 2024CHF 414.4bCHF 120.1bCHF 18.8b27.3x22.1x3.5x
Sat, 23 Dec 2023CHF 394.7bCHF 119.7bCHF 18.7b25x21.1x3.3x
Mon, 20 Nov 2023CHF 386.7bCHF 121.6bCHF 18.9b23.9x20.4x3.2x
Wed, 18 Oct 2023CHF 407.4bCHF 121.5bCHF 18.6b26.2x21.9x3.4x
Fri, 15 Sep 2023CHF 409.8bCHF 112.6bCHF 18.0b47.1x22.7x3.6x
Sun, 13 Aug 2023CHF 413.3bCHF 111.6bCHF 17.9b48.5x23.1x3.7x
Tue, 11 Jul 2023CHF 405.4bCHF 114.7bCHF 18.8b35.4x21.5x3.5x
Thu, 08 Jun 2023CHF 431.8bCHF 115.8bCHF 19.0b37.7x22.8x3.7x
Sat, 06 May 2023CHF 436.5bCHF 114.9bCHF 18.8b42x23.2x3.8x
Mon, 03 Apr 2023CHF 412.5bCHF 115.8bCHF 18.9b42x21.8x3.6x
Wed, 01 Mar 2023CHF 399.1bCHF 116.9bCHF 19.1b27x20.9x3.4x
Fri, 27 Jan 2023CHF 445.4bCHF 118.0bCHF 34.9b23.9x12.8x3.8x
Sun, 25 Dec 2022CHF 438.2bCHF 117.6bCHF 34.8b22.8x12.6x3.7x
Tue, 22 Nov 2022CHF 443.2bCHF 118.9bCHF 35.4b22.9x12.5x3.7x
Thu, 20 Oct 2022CHF 448.1bCHF 121.8bCHF 37.5b21.1x11.9x3.7x
Sat, 17 Sep 2022CHF 449.6bCHF 119.7bCHF 36.6b21.5x12.3x3.8x
Mon, 15 Aug 2022CHF 446.6bCHF 118.6bCHF 36.2b21.4x12.4x3.8x
Price to Earnings Ratio

12.4x


Total Market Cap: CHF 446.6bTotal Earnings: CHF 36.2bTotal Revenue: CHF 118.6bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Pharma Industry Price to Earnings3Y Average 20.5x202320242025
Current Industry PE
  • Investors are relatively neutral on the Swiss Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 20.5x.
  • The industry is trading close to its 3-year average PS ratio of 3.7x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have declined 17% per year over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Swiss Healthcare industry?

CH Market0.25%
Healthcare-1.80%
Pharma-1.54%
Pharma-1.54%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
SDZ Sandoz GroupCHF 50.528.1%
+CHF 1.6b		44.6%PS2.6x
GALD Galderma GroupCHF 130.402.3%
+CHF 688.5m		76.2%PE101.6x
NWRN Newron PharmaceuticalsCHF 7.194.4%
+CHF 6.0m		-1.8%PE9.6x
CURN Curatis HoldingCHF 12.300.8%
+CHF 499.2k		118.9%n/a

Latest News

SDZ
CHF 50.52
Sandoz Group
7D
8.1%
1Y
44.6%
NOVN
CHF 93.05
Novartis
7D
-1.2%
1Y
-3.2%
ROG
CHF 249.10
Roche Holding
7D
-3.1%
1Y
-9.6%
ADXN
CHF 0.056
Addex Therapeutics
7D
-5.4%
1Y
-3.8%
COPN
CHF 55.70
Cosmo Pharmaceuticals
7D
-4.8%
1Y
-25.4%
GALD
CHF 130.40
Galderma Group
7D
2.3%
1Y
76.2%
BIOV
CHF 28.00
BioVersys
7D
-17.6%
1Y
n/a
DESN
CHF 302.00
Dottikon ES Holding
7D
-5.0%
1Y
20.1%

Here's Why Dottikon ES Holding (VTX:DESN) Has Caught The Eye Of Investors

Jun 18
Here's Why Dottikon ES Holding (VTX:DESN) Has Caught The Eye Of Investors
CURN
CHF 12.30
Curatis Holding
7D
0.8%
1Y
118.9%
NWRN
CHF 7.19
Newron Pharmaceuticals
7D
4.4%
1Y
-1.8%